The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
A cytokine-mediated link between innate immunity, inflammation, and cancer
Open accessAbstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After chronic stress breaks this balance through a long-term pro-inflammatory response, these cells and cytokines can act on all stages of tumor development, including initiation, promotion, malignant transformation, invasion, and metastasis through mutation, epigenetic modification, and regulation of the tumor microenvironment [(50, 51); Figure 3].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Flagged first, then by citations
Research works printed but not linked: 12
- Shacter, 2002, Oncology., 16, 217
- Sehouli, 2002, Anticancer Res., 22, 3421
- Kitakata, 2002, Cancer Res., 62, 6682
- Gado, 2001, Haematologica., 86, 227
- Tartour, 1999, Cancer Res., 59, 3698
- Trinchieri, 2003, Nat. Rev., 3, 133
- Erdman, 2003, Cancer Res., 63, 6042
- Kohno, 2003, Cancer Res., 63, 5091
- Alas, 2001, Clin. Cancer Res., 7, 709
- Lech-Maranda, 2006, Eur. Cytokine Netw., 17, 60
- Parsons, 1995, Cancer Res., 55, 5548
- Engle, 2002, Cancer Res., 62, 6362
Cited by
Sorted by citations
Items 301–400 of 999
Chen, H., Liao, H., Liu, Y., Zheng, Y., Wu, X., Su, Z., Zhang, X., Lai, Z., Lai, X., Lin, Z., et al. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.11.017 · Cited by 106
Cheung, K. L., Khor, T. O., & Kong, A. T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9734-9 · Cited by 106
Rehman, M. U., Yoshihisa, Y., Miyamoto, Y., & Shimizu, T. (2012) · Inflammation Research · doi:10.1007/s00011-012-0512-0 · Cited by 106
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
Rasul, A., Khan, M. N., Ali, M., Li, J., & Li, X. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/248532 · Cited by 108
Gu, K., Li, M., Shen, J., Liu, F., Cao, J., Jin, S., & Yu, Y. (2015) · PubMed Central · Cited by 105
Molecular mechanisms involved in dendritic cell dysfunction in cancer
Tang, M., Diao, J., & Cattral, M. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2317-8 · Cited by 106
Wong, C. C., Baum, J., Silvestro, A., Beste, M. T., Dharan, B., Xu, S., Wang, Y. A., Wang, T., PRESCOTT, M. F., Krajkovich, L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3176 · Cited by 105
Cytokine-based transformation of immune surveillance into tumor-promoting inflammation
Mumm, J. B., & Oft, M. (2008) · Oncogene · doi:10.1038/onc.2008.275 · Cited by 108
Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1320-y · Cited by 106
Kacevska, M., Robertson, G. R., Clarke, S. J., & Liddle, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.137 · Cited by 104
Choi, Y. H., Jin, G. Y., Li, G. Z., & Yan, G. H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.959 · Cited by 103
Ligibel, J. A., Barry, W. T., Alfano, C. M., Hershman, D. L., Irwin, M. L., Neuhouser, M. L., Thomson, C. A., Delahanty, L. M., Frank, E. S., Spears, P., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0040-8 · Cited by 104
Guthrie, G. J. K., Roxburgh, C. S. D., Horgan, P. G., & McMillan, D. C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.003 · Cited by 103
Sturm, C., & Wagner, A. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091890 · Cited by 101
The role of immunity in elderly cancer
Malaguarnera, L., Cristaldi, E., & Malaguarnera, M. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.06.002 · Cited by 103
Beaver, L. M., Stemmy, E. J., Schwartz, A. M., Damsker, J. M., Constant, S. L., Ceryak, S. M., & Patierno, S. R. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0900715 · Cited by 104
Li, R., Huang, Y., & Lin, J. (2020) · Nature Communications · doi:10.1038/s41467-019-14065-6 · Cited by 102
Li, J., Xia, Y., Sun, B., Zheng, N., Li, Y., Pang, X., Yang, F., Zhao, X., Ji, Z., Yu, H., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01112-5 · Cited by 108
NF-κB: Governing Macrophages in Cancer
Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., & Franzoso, G. (2024) · Genes · doi:10.3390/genes15020197 · Cited by 108
Li, B., Xu, X. J., Wang, X., Yu, H., Li, X., Tao, W., Wang, Y., & Yang, L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013501 · Cited by 100
Flavone deglycosylation increases their anti‐inflammatory activity and absorption
Hostetler, G. L., Riedl, K. M., Cárdenas, H., Toro, M. D., Arango, D., Schwartz, S. J., & Doseff, A. I. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100596 · Cited by 100
Diet components can suppress inflammation and reduce cancer risk
Hardman, W. E. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.3.233 · Cited by 100
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña‐Oyarzún, D., Bravo, R., Díaz‐Vegas, A., Aleman, L., Chiong, M., García, L., Claudia Bambs, S., Troncoso, R., Cifuentes, M., Morselli, E., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.084 · Cited by 108
Ingale, S., Wolfert, M. A., Buskas, T., & Boons, G. (2009) · ChemBioChem · doi:10.1002/cbic.200800596 · Cited by 99
Photoaging and skin cancer: Is the inflammasome the missing link?
Awad, F., Assrawi, E., Louvrier, C., Jumeau, C., Giurgea, I., Amselem, S., & Karabina, S. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.003 · Cited by 101
Badoual, C., Bouchaud, G., Agueznay, N. E. H., Mortier, E., Hans, S., Gey, A., Fernani, F., Peyrard, S., Laurent‐Puig, P., Bruneval, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6842 · Cited by 98
Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary Disease
Choudhury, G., Rabinovich, R., & MacNee, W. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.007 · Cited by 101
The complex interplay between inflammation, the microbiota and colorectal cancer
Arthur, J. C., & Jobin, C. (2013) · Gut Microbes · doi:10.4161/gmic.24220 · Cited by 99
Shah, H. K., Sharma, T., & Banerjee, B. D. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125691 · Cited by 96
Links between Infections, Lung Cancer, and the Immune System
Budişan, L., Zănoagă, O., Braicu, C., Pîrlog, R., Covaliu, B. F., Eşanu, V., Korban, S. S., & Berindan‐Neagoe, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179394 · Cited by 107
Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway
Xiang, W., Feng, W.-F., Ke, W., Sun, Z., Chen, Z., & Liu, W. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.006 · Cited by 95
Suicide and cancer: Where do we go from here?
Spoletini, I., Gianni, W., Caltagirone, C., Madaio, R., Repetto, L., & Spalletta, G. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.05.005 · Cited by 164
Martinez, R. M., Pinho-Ribeiro, F. A., Steffen, V. S., Silva, T. C. C., Caviglione, C. V., Bottura, C., Fonseca, M. J. V., Vicentini, F. T. M. C., Vignoli, J. A., Baracat, M. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146296 · Cited by 96
Inflammation in uveal melanoma
Bronkhorst, I. H. G., & Jager, M. J. (2012) · Eye · doi:10.1038/eye.2012.253 · Cited by 96
The Nuclear Hormone Receptor PPARγas a Therapeutic Target in Major Diseases
Schmidt, M. V., Brüne, B., & von Knethen, A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.213 · Cited by 94
An immunologic portrait of cancer
Ascierto, M. L., Giorgi, V. D., Liu, Q., Bedognetti, D., Spivey, T., Murtas, D., Uccellini, L., Ayotte, B. D., Stroncek, D. F., Chouchane, L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-146 · Cited by 94
Qiu, H., Hu, X., He, C. H., Yu, B., Li, Y., & Li, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00012 · Cited by 95
Harpaz, N., & Polydorides, A. D. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.876 · Cited by 96
Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression
Schmitz, M. L., & Kracht, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.10.004 · Cited by 94
Metabolic syndrome, obesity and cancer risk
Belladelli, F., Montorsi, F., & Martini, A. (2022) · Current Opinion in Urology · doi:10.1097/mou.0000000000001041 · Cited by 94
Role of the nervous system in cancer metastasis
Li, S., Sun, Y., & GAO, D. (2013) · Oncology Letters · doi:10.3892/ol.2013.1168 · Cited by 94
Negri, L., & Ferrara, N. (2018) · Physiological Reviews · doi:10.1152/physrev.00012.2017 · Cited by 99
Ciążyńska, M. A., Olejniczak‐Staruch, I., Sobolewska-Sztychny, D., Narbutt, J., Skibińska, M., & Lesiak, A. (2021) · Life · doi:10.3390/life11040326 · Cited by 100
Recent Advances in the Research of Hepatitis B Virus-Related Hepatocellular Carcinoma
Kao, J., Chen, P., & Chen, D. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00002-9 · Cited by 93
Novel biphasic role for lymphocytes revealed during resolving inflammation
Rajakariar, R., Lawrence, T., Byström, J., Hilliard, M., Colville‐Nash, P., Bellingan, G. J., Fitzgerald, D. J., Yaqoob, M., & Gilroy, D. W. (2008) · Blood · doi:10.1182/blood-2007-08-108936 · Cited by 92
Giorgi, V. S. I., Peraçoli, M. T. S., Peraçoli, J. C., Witkin, S. S., & Castro, C. F. B. (2012) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.06.004 · Cited by 93
Kim, J. Y., Lim, S., Kim, G., Yun, H. J., Ahn, S. G., & Choi, H. S. (2014) · Oncogene · doi:10.1038/onc.2014.418 · Cited by 92
Sun, Y., Liu, N., Guan, X., Wu, H., Sun, Z., & Zeng, H. (2016) · Mediators of Inflammation · doi:10.1155/2016/5715719 · Cited by 92
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2019) · Cells · doi:10.3390/cells8070726 · Cited by 94
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
Hosseini, A., Gharibi, T., Marofi, F., Javadian, M., Babaloo, Z., & Baradaran, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29593 · Cited by 94
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals
Oh, J., Cho, M.-C., Kim, J., Lee, S. Y., Kim, H. J., Park, E. S., Ban, J. O., Kang, J.-W., Lee, D.-H., Shim, J.-H., et al. (2011) · Oncogene · doi:10.1038/onc.2011.52 · Cited by 93
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 99
Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy
Xu, M., Hu, Y., Wu, J., Liu, J., & Pu, K. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c13022 · Cited by 93
Tamburini, B. A. J., Phang, T. L., Fosmire, S. P., Scott, M. C., Trapp, S., Duckett, M. M., Robinson, S. R., Slansky, J. E., Sharkey, L. C., Cutter, G., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-619 · Cited by 91
Hong, Y., Chao, W., Chen, M., & Lin, B. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-64 · Cited by 91
Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b+Gr1+ Cells
Qu, X., Zhuang, G., Yu, L., Meng, G., & Ferrara, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326801 · Cited by 96
Okumura, T., Ericksen, R. E., Takaishi, S., Wang, S. S. W., Dubeykovskiy, Z., Shibata, W., Betz, K. S., Muthupalani, S., Rogers, A. B., Fox, J. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1506 · Cited by 91
Souto, J. C., Vila, L., & Brú, A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20185 · Cited by 90
Murphy, A., Casey, A., Byrne, G., Chambers, G., & Howe, O. L. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3315 · Cited by 91
Kaler, P., Galea, V. P., Augenlicht, L. H., & Klampfer, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011700 · Cited by 89
Gialluisi, A., Bonaccio, M., Castelnuovo, A. F. D., Costanzo, S., Curtis, A. D., Sarchiapone, M., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.041 · Cited by 94
Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer
Xiong, Y., Wang, Y., & Tiruthani, K. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102034 · Cited by 88
Li, J., Lan, T., Zhang, C., Zeng, C., Hou, J., Yang, Z., Zhang, M., Liu, J., & Liu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.2671 · Cited by 93
Olsen, C. J., Moreira, J. M. A., Lukanidin, E. M., & Ambartsumian, N. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-444 · Cited by 90
Sun, K., Guo, X.-L., Zhao, Q.-D., Jing, Y.-Y., Kou, X.-R., Xie, X.-Q., Zhou, Y., Cai, N., Gao, L., Zhao, X., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.35 · Cited by 91
Tumor stress, cell death and the ensuing immune response
Ullrich, E., Bonmort, M., Mignot, G., Kroemer, G., & Zitvogel, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402266 · Cited by 90
Brandon‐Warner, E., Walling, T. L., Schrum, L. W., & McKillop, I. H. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01660.x · Cited by 88
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 88
Misiewicz, A., & Dymicka-Piekarska, V. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s391932 · Cited by 87
A Review of Mathematical Models of Cancer–Immune Interactions in the Context of Tumor Dormancy
Wilkie, K. P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1445-2_10 · Cited by 87
Guo, S., Qiu, P., Xu, G. H., Wu, X., Dong, P., Yang, G., Zheng, J., McClements, D. J., & Xiao, H. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300129t · Cited by 87
Raggi, C., Invernizzi, P., & Andersen, J. B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.007 · Cited by 87
Humoral innate immune response and disease
Shishido, S. N., Varahan, S., Yuan, K., Li, X., & Fleming, S. D. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.06.002 · Cited by 88
Shaykhiev, R., Behr, J., & Bals, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001393 · Cited by 86
Schiechl, G., Bauer, B., Fuss, I. J., Lang, S. A., Moser, C., Ruemmele, P., Rose‐John, S., Neurath, M. F., Geissler, E. K., Schlitt, H. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42540 · Cited by 87
CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
Jia, Y., Wang, L., Hu, G.-S., Zhang, Y., Du, J., Ding, J., Ji, X., Shen, H., Huang, H., Ye, F., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112408 · Cited by 92
Suppression of Implanted MDA-MB 231 Human Breast Cancer Growth in Nude Mice by Dietary Walnut
Hardman, W. E., & Ion, G. (2008) · Nutrition and Cancer · doi:10.1080/01635580802065302 · Cited by 86
Shojaei, S., Hashemi, S. M., Ghanbarian, H., Salehi, M., & Mohammadi‐Yeganeh, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27326 · Cited by 89
Depression and cancer: An unexplored and unresolved emergent issue in elderly patients
Spoletini, I., Gianni, W., Repetto, L., Bria, P., Caltagirone, C., Bossù, P., & Spalletta, G. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.10.005 · Cited by 84
Abdolalipour, E., Mahooti, M., Salehzadeh, A., Torabi, A., Mohebbi, S. R., Gorji, A., & Ghaemi, A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104207 · Cited by 83
Liao, R., Sun, T., Yi, Y., Wu, H., Li, Y., Wang, J., Zhou, J., Shi, Y., Cheng, Y., Qiu, S., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02273.x · Cited by 83
Impact of Toll-like receptor 4 polymorphisms on risk of cancer
Kutikhin, A. G. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.11.003 · Cited by 83
Neil, J. R., & Schiemann, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3094 · Cited by 83
Johansen, J. S., Bojesen, S. E., Mylin, A. K., Frikke‐Schmidt, R., Price, P. A., & Nordestgaard, B. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8367 · Cited by 83
Kell, D. B., & Pretorius, E. (2014) · Integrative Biology · doi:10.1039/c4ib00173g · Cited by 81
Markopoulos, G. S., Roupakia, E., Marcu, K. B., & Kolettas, E. (2019) · Cells · doi:10.3390/cells8101143 · Cited by 84
Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?
Tsujimoto, H., Ono, S., Ichikura, T., Matsumoto, Y., Yamamoto, J., & Hase, K. (2010) · Gastric Cancer · doi:10.1007/s10120-010-0568-x · Cited by 82
Beatty, P. L., Narayanan, S., Gariépy, J., Ranganathan, S., & Finn, O. J. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0194 · Cited by 82
Exploring the immunomodulatory and anticancer properties of zerumbone
Haque, M. A., Jantan, I., Arshad, L., & Bukhari, S. N. A. (2017) · Food & Function · doi:10.1039/c7fo00595d · Cited by 82
Role of Cytokines in Genesis, Progression and Prognosis of Cervical Cancer
Paradkar, P. H., Joshi, J. V., Mertia, P. N., Agashe, S., & Vaidya, R. A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.9.3851 · Cited by 84
Nanotheranostics to target antibiotic-resistant bacteria: Strategies and applications
Bhattacharjee, R., Negi, A., Bhattacharya, B., Dey, T., Mitra, P., Preetam, S., Kumar, L., Kar, S., Das, S. S., Iqbal, D., et al. (2023) · OpenNano · doi:10.1016/j.onano.2023.100138 · Cited by 86
Tanaka, T., de Azevedo, M. B. M., Durán, N., Alderete, J. B., Epifano, F., Genovese, S., Tanaka, M., Tanaka, T., & Curini, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24833 · Cited by 81
Schürch, C. M., Roelli, M. A., Forster, S., Wasmer, M.-H., Bruehl, F. K., Maire, R., Pancrazio, S. D., Ruepp, M., Giger, R., Perren, A. A., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0555 · Cited by 81
YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
Schultz, N. A., & Johansen, J. S. (2010) · Cancers · doi:10.3390/cancers2031453 · Cited by 79
Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
Hao, Q., Wu, Y., Wu, Y., Wang, P., & Vadgama, J. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031461 · Cited by 83
Nardin, A. (2008) · Frontiers in bioscience · doi:10.2741/2944 · Cited by 80
Shao, J., Li, Y., Wang, Z., Xiao, M., Yin, P., Lü, Y., Qian, X. H., Xu, Y. F., & Liu, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.008 · Cited by 79
Characterization and Regulation of Bv8 in Human Blood Cells
Zhong, C., Qu, X., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1954 · Cited by 78
Melatonin's role as a co-adjuvant treatment in colonic diseases: A review
Zubero, E. E., López‐Pingarrón, L., Alatorre-Jiménez, M. A., Ochoa-Moneo, P., Celia, B.-R., Rivas-Jiménez, M., Castán-Ruiz, S., Antoñanzas-Lombarte, Á., Tan, D., García, J. J., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.11.031 · Cited by 81
p38 MAPK Controls Prothrombin Expression by Regulated RNA 3′ End Processing
Danckwardt, S., Gantzert, A.-S., Macher‐Goeppinger, S., Probst, H. C., Gentzel, M., Wilm, M. S., Gröne, H., Schirmacher, P., Hentze, M. W., & Kulozik, A. E. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.032 · Cited by 79
Metadata
- Authors
- Lin, W.-W., & Karin, M.
- Affiliations
- National Taiwan University (TW)
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1175-1183
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1857251
- OpenAlex
- W2133439754
- Cited by
- 1,940
- References
- 128
- Citations by year
- 2026: 18 · 2025: 39 · 2024: 60 · 2023: 92 · 2022: 93 · 2021: 117 · 2020: 117 · 2019: 102 · 2018: 93 · 2017: 123 · 2016: 104 · 2015: 127 · 2014: 134 · 2013: 130 · 2012: 124
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- cytokines, innate immunity, inflammation, cancer, chronic inflammation, tumor microenvironment, tumor promotion, tumor progression, infection and cancer, tumor initiation, inflammatory cells
- MeSH terms
- Animals, Humans, Immunity, Innate, Inflammation, Neoplasms, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review